Medicine
Bupropion 75 mg tablet
Bupropion 75 mg tablet is a generic prescription medicine for oral use, made by 23 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20ºC to 25ºC (68ºF to 77ºF), excursions permitted from 15ºC to 30ºC…
Key facts
- Active ingredient (INN)
- Bupropion
- Brand
- Sold under the generic name
- Strength
- 75 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 10 blister pack and 67 more
- Manufacturers
- Alembic PharmaceuticalsIndiaCadila PharmaceuticalsIndiaCiplaIndiaAvet PharmaceuticalsIndiaAurobindo PharmaIndiaBryant Ranch PrepackApotexModavar PharmaceuticalsAmici PharmaChartwell RX23 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20ºC to 25ºC (68ºF to 77ºF), excursions permitted from 15ºC to 30ºC (59ºF to 86ºF). Protect from moisture. Store in a tight, light resistant container.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N06AX12 Bupropion
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 17 January 2006
- Identifiers
- RxCUI 993687, 993691DailyMed set ID 13560bf8-eb25-44f0-968e-db70d51219af, 64934ca2-5655-45a2-9016-ad65b5abf5d3, 144379e1-93b7-41c1-bc3a-7bdec5afa309 +32NDC 82804-127, 55154-8180, 71335-0791 +32Application ANDA076143, ANDA206975, ANDA203013 +4
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 23 labelers. The register lists 70 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 bottle | 46708-118-31 | Alembic PharmaceuticalsIndia | 18 June 2018 |
| 1000 tablet, film coated in 1 bottle | 46708-118-91 | Alembic PharmaceuticalsIndia | 18 June 2018 |
| 100 tablet, film coated in 1 bottle | 62332-118-31 | Alembic PharmaceuticalsIndia | 10 January 2024 |
| 1000 tablet, film coated in 1 bottle | 62332-118-91 | Alembic PharmaceuticalsIndia | 10 January 2024 |
| 100 tablet, film coated in 1 bottle | 59651-874-01 | Aurobindo PharmaIndia | 25 April 2024 |
| 100 tablet in 1 bottle | 23155-191-01 | Avet PharmaceuticalsIndia | 19 August 2016 |
| 1000 tablet in 1 bottle | 23155-191-10 | Avet PharmaceuticalsIndia | 19 August 2016 |
| 100 tablet, film coated in 1 bottle | 71209-052-05 | Cadila PharmaceuticalsIndia | 12 January 2023 |
| 1000 tablet, film coated in 1 bottle | 71209-052-11 | Cadila PharmaceuticalsIndia | 12 January 2023 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 71209-052-17 | Cadila PharmaceuticalsIndia | 12 January 2023 |
| 30 tablet in 1 bottle | 69097-917-02 | CiplaIndia | 26 May 2018 |
| 100 tablet in 1 bottle | 69097-917-07 | CiplaIndia | 26 May 2018 |
| 1000 tablet in 1 bottle | 69097-917-15 | CiplaIndia | 26 May 2018 |
| 100 tablet, film coated in 1 bottle | 69292-601-01 | Amici Pharma | 21 May 2026 |
| 100 tablet, film coated in 1 bottle | 60505-0158-1 | Apotex | 17 January 2006 |
| 30 tablet, film coated in 1 bottle | 60505-0158-3 | Apotex | 17 January 2006 |
| 500 tablet, film coated in 1 bottle | 60505-0158-5 | Apotex | 17 January 2006 |
| 1000 tablet, film coated in 1 bottle | 60505-0158-7 | Apotex | 17 January 2006 |
| 90 tablet, film coated in 1 bottle | 60505-0158-9 | Apotex | 17 January 2006 |
| 90 tablet in 1 bottle | 62135-723-90 | Chartwell RX | 11 August 2023 |
| 100 tablet, film coated in 1 bottle | 72241-020-05 | Modavar Pharmaceuticals | 12 January 2023 |
| 1000 tablet, film coated in 1 bottle | 72241-020-11 | Modavar Pharmaceuticals | 12 January 2023 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 72241-020-17 | Modavar Pharmaceuticals | 12 January 2023 |
| 30 tablet, film coated in 1 bottle | 71335-0013-1 | Bryant Ranch Prepack | 8 March 2018 |
| 60 tablet, film coated in 1 bottle | 71335-0013-2 | Bryant Ranch Prepack | 21 February 2018 |
| 90 tablet, film coated in 1 bottle | 71335-0013-3 | Bryant Ranch Prepack | 9 July 2024 |
| 7 tablet, film coated in 1 bottle | 71335-0013-4 | Bryant Ranch Prepack | 9 July 2024 |
| 14 tablet, film coated in 1 bottle | 71335-0013-5 | Bryant Ranch Prepack | 9 July 2024 |
| 120 tablet, film coated in 1 bottle | 71335-0013-6 | Bryant Ranch Prepack | 9 July 2024 |
| 100 tablet, film coated in 1 bottle | 71335-0013-7 | Bryant Ranch Prepack | 9 July 2024 |
| 30 tablet in 1 bottle | 71335-0791-1 | Bryant Ranch Prepack | 26 April 2018 |
| 60 tablet in 1 bottle | 71335-0791-2 | Bryant Ranch Prepack | 19 June 2019 |
| 90 tablet in 1 bottle | 71335-0791-3 | Bryant Ranch Prepack | 19 June 2019 |
| 7 tablet in 1 bottle | 71335-0791-4 | Bryant Ranch Prepack | 19 June 2019 |
| 14 tablet in 1 bottle | 71335-0791-5 | Bryant Ranch Prepack | 19 June 2019 |
| 120 tablet in 1 bottle | 71335-0791-6 | Bryant Ranch Prepack | 19 June 2019 |
| 100 tablet in 1 bottle | 71335-0791-7 | Bryant Ranch Prepack | 19 June 2019 |
| 100 tablet in 1 bottle | 71335-2867-1 | Bryant Ranch Prepack | 22 October 2025 |
| 100 tablet, film coated in 1 bottle | 72162-2098-1 | Bryant Ranch Prepack | 17 January 2006 |
| 100 tablet in 1 bottle | 72162-2400-1 | Bryant Ranch Prepack | 2 October 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 30 December 1985 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Bupropion
Clinical summary
Bupropion is an aminoketone indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM). It is available as extended-release tablets and tablets for oral use. MedsAcross supplies Bupropion for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about BupropionFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- WELLBUTRIN SR prescribing information (GlaxoSmithKline) · U.S. National Library of Medicine, DailyMed
Need Bupropion 75 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.